Kenta NakamuraBrian S. SchwartzNiklas LindegårdhChris KehB. Joseph GuglielmoUCSF School of MedicineUniversity of California, San FranciscoMahidol University2018-09-242018-09-242010-04-01Clinical Infectious Diseases. Vol.50, No.7 (2010)105848382-s2.0-77749326569https://repository.li.mahidol.ac.th/handle/123456789/29721The safety of high-dose oseltamivir during treatment of 2009 H1N1 influenza A infection for critically ill patients is unknown. Here we report on a case patient with severe, delayed-onset neuropsychiatric symptoms after administration of high-dose oseltamivir. Clinicians should be vigilant to the possible increased risk of complications associated with high-dose oseltamivir therapy for 2009 H1N1 influenza A infection. © 2010 by the Infectious Diseases Society of America. All rights reserved.Mahidol UniversityMedicineArticleSCOPUS10.1086/651166